TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
JRS Pharma Oy
Closing information (x1000 SEK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
104,356
|
103,673
|
106,079 |
Financial expenses |
19
|
18
|
29 |
Earnings before taxes |
21,114
|
19,302
|
16,643 |
Total assets |
63,275
|
53,412
|
66,275 |
Current assets |
29,351
|
19,640
|
31,173 |
Current liabilities |
13,996
|
14,241
|
13,931 |
Equity capital |
48,657
|
38,340
|
51,346 |
- share capital |
1,607
|
1,535
|
1,599 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
76.9%
|
71.8%
|
77.5% |
Turnover per employee | |||
Profit as a percentage of turnover |
20.2%
|
18.6%
|
15.7% |
Return on assets (ROA) |
33.4%
|
36.2%
|
25.2% |
Current ratio |
209.7%
|
137.9%
|
223.8% |
Return on equity (ROE) |
43.4%
|
50.3%
|
32.4% |
Change turnover |
-4,219
|
1,836
|
10,762 |
Change turnover % |
-4%
|
2%
|
11% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.